Neurocrine Biosciences shares owned by Grandfield & Dodd
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Grandfield & Dodd
from 13F filings
Historical chart of Grandfield & Dodd investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Grandfield & Dodd consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Grandfield & Dodd
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.8M | 16k | 115.22 |
| 2024-06-30 | $2.1M | 16k | 137.67 |
| 2024-03-31 | $2.2M | 16k | 137.92 |
| 2023-12-31 | $2.0M | 15k | 131.76 |
| 2023-09-30 | $1.7M | 15k | 112.50 |
| 2023-06-30 | $1.4M | 15k | 94.30 |
| 2023-03-31 | $1.5M | 15k | 101.22 |
| 2022-12-31 | $1.8M | 15k | 119.44 |
| 2022-09-30 | $1.5M | 14k | 106.45 |
| 2022-06-30 | $1.4M | 14k | 97.65 |
| 2022-03-31 | $1.3M | 14k | 93.50 |
| 2021-12-31 | $1.1M | 13k | 85.41 |
| 2021-09-30 | $1.1M | 12k | 95.74 |
| 2021-06-30 | $1.1M | 12k | 97.08 |
| 2021-03-31 | $1.1M | 12k | 96.94 |
| 2020-12-31 | $1.1M | 11k | 95.79 |
| 2020-09-30 | $1.1M | 11k | 96.25 |
| 2020-06-30 | $1.3M | 11k | 122.33 |
| 2020-03-31 | $903k | 10k | 86.53 |
| 2019-12-31 | $1.1M | 10k | 107.54 |
| 2019-09-30 | $853k | 9.5k | 90.11 |
| 2019-06-30 | $727k | 8.6k | 84.43 |
| 2019-03-31 | $694k | 7.9k | 88.06 |
| 2018-12-31 | $558k | 7.8k | 71.36 |
| 2018-09-30 | $953k | 7.8k | 122.89 |
| 2018-06-30 | $755k | 7.7k | 98.24 |
| 2018-03-31 | $634k | 7.6k | 82.93 |
| 2017-12-31 | $614k | 7.9k | 77.57 |
| 2017-09-30 | $466k | 7.6k | 61.24 |
| 2017-06-30 | $282k | 6.1k | 46.00 |
| 2017-03-31 | $230k | 5.3k | 43.23 |